Kohjin Bio Co.,Ltd.(JP:177A)
Â¥654.00-10.00 (-1.51%)
JP:177A
Kohjin Bio Co.,Ltd. financials statements
Â¥654.00
At close:-10.00 (-1.51%)
Want to see JP:177A full AI Analyst Report?
Kohjin Bio Co.,Ltd. (177A) Ratios
0 Followers
Kohjin Bio Co.,Ltd. Ratios
JP:177A's free cash flow for Q2 2026 was ¥0.00. For the 2026 fiscal year, JP:177A's free cash flow was increased by ¥0.00 and operating cash flow was ¥0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 26 | Mar 25 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.04 | 1.80 | 1.42 | 1.15 | 1.56 |
| Quick Ratio | 1.68 | 1.43 | 1.14 | 0.79 | 1.33 |
| Cash Ratio | 1.27 | 1.05 | 0.72 | 0.48 | 0.79 |
| Solvency Ratio | 0.35 | 0.22 | 0.21 | 0.32 | 0.23 |
| Operating Cash Flow Ratio | 0.37 | 0.29 | 0.34 | 0.15 | 0.35 |
| Short-Term Operating Cash Flow Coverage | 0.55 | 0.42 | 0.50 | 0.22 | 0.69 |
| Net Current Asset Value | ¥ 1.73B | ¥ 1.31B | ¥ 162.90M | ¥ 361.95M | ¥ 55.54M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.26 | 0.25 | 0.37 | 0.34 | 0.40 |
| Debt-to-Equity Ratio | 0.41 | 0.37 | 0.74 | 0.70 | 1.01 |
| Debt-to-Capital Ratio | 0.29 | 0.27 | 0.42 | 0.41 | 0.50 |
| Long-Term Debt-to-Capital Ratio | 0.06 | 0.04 | 0.14 | 0.00 | 0.32 |
| Financial Leverage Ratio | 1.58 | 1.50 | 1.97 | 2.03 | 2.52 |
| Debt Service Coverage Ratio | 0.71 | 0.41 | 0.42 | 0.49 | 0.70 |
| Interest Coverage Ratio | 32.96 | 8.98 | 26.09 | 39.04 | 24.90 |
| Debt to Market Cap | 0.23 | 0.30 | 0.22 | 0.21 | 0.18 |
| Interest Debt Per Share | 472.88 | 436.18 | 598.46 | 512.02 | 452.19 |
| Net Debt to EBITDA | -0.54 | -0.38 | 0.78 | 0.44 | 0.43 |
| Profitability Margins | |||||
| Gross Profit Margin | 45.45% | 37.60% | 39.44% | 51.74% | 51.66% |
| EBIT Margin | 20.08% | 7.50% | 13.80% | 26.92% | 24.35% |
| EBITDA Margin | 27.01% | 15.52% | 20.09% | 30.45% | 28.88% |
| Operating Profit Margin | 19.04% | 6.92% | 12.51% | 26.72% | 24.56% |
| Pretax Profit Margin | 19.50% | 6.73% | 13.32% | 26.24% | 23.36% |
| Net Profit Margin | 15.27% | 5.08% | 8.05% | 17.50% | 14.89% |
| Continuous Operations Profit Margin | 15.27% | 5.08% | 8.07% | 17.50% | 14.89% |
| Net Income Per EBT | 78.28% | 75.55% | 60.42% | 66.69% | 63.73% |
| EBT Per EBIT | 102.44% | 97.28% | 106.50% | 98.17% | 95.10% |
| Return on Assets (ROA) | 8.71% | 2.82% | 5.83% | 13.53% | 10.50% |
| Return on Equity (ROE) | 13.75% | 4.22% | 11.49% | 27.50% | 26.51% |
| Return on Capital Employed (ROCE) | 14.94% | 5.23% | 14.24% | 40.71% | 28.54% |
| Return on Invested Capital (ROIC) | 9.31% | 3.13% | 6.13% | 16.26% | 13.65% |
| Return on Tangible Assets | 8.74% | 2.83% | 5.83% | 13.54% | 10.51% |
| Earnings Yield | 8.89% | 4.06% | 3.89% | 8.41% | 4.94% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.32 | 7.37 | 6.38 | 7.02 | 4.98 |
| Payables Turnover | 21.18 | 16.78 | 17.67 | 15.64 | 8.74 |
| Inventory Turnover | 3.22 | 3.53 | 4.23 | 2.08 | 3.66 |
| Fixed Asset Turnover | 1.60 | 1.30 | 1.84 | 2.18 | 2.31 |
| Asset Turnover | 0.57 | 0.55 | 0.72 | 0.77 | 0.71 |
| Working Capital Turnover Ratio | 2.90 | 2.21 | 6.49 | 5.60 | 0.00 |
| Cash Conversion Cycle | 153.66 | 131.01 | 122.84 | 204.48 | 131.22 |
| Days of Sales Outstanding | 57.71 | 49.51 | 57.19 | 51.98 | 73.35 |
| Days of Inventory Outstanding | 113.18 | 103.26 | 86.30 | 175.84 | 99.62 |
| Days of Payables Outstanding | 17.23 | 21.76 | 20.65 | 23.34 | 41.76 |
| Operating Cycle | 170.89 | 152.77 | 143.49 | 227.81 | 172.97 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 179.16 | 136.65 | 197.76 | 110.72 | 152.14 |
| Free Cash Flow Per Share | 5.49 | -54.93 | 62.64 | -23.91 | 111.55 |
| Dividend Paid and CapEx Coverage Ratio | 0.97 | 0.63 | 1.28 | 0.77 | 3.21 |
| Capital Expenditure Coverage Ratio | 1.03 | 0.71 | 1.46 | 0.82 | 3.75 |
| Operating Cash Flow Coverage Ratio | 0.38 | 0.32 | 0.33 | 0.22 | 0.34 |
| Operating Cash Flow to Sales Ratio | 0.18 | 0.14 | 0.17 | 0.10 | 0.19 |
| Free Cash Flow Yield | 0.31% | -4.54% | 2.64% | -1.01% | 4.71% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 11.25 | 24.64 | 25.71 | 11.90 | 20.22 |
| Price-to-Sales (P/S) Ratio | 1.72 | 1.25 | 2.07 | 2.08 | 3.01 |
| Price-to-Book (P/B) Ratio | 1.55 | 1.04 | 2.95 | 3.27 | 5.36 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 318.77 | -22.03 | 37.84 | -99.14 | 21.25 |
| Price-to-Operating Cash Flow Ratio | 9.77 | 8.85 | 11.98 | 21.41 | 15.58 |
| Price-to-Earnings Growth (PEG) Ratio | 0.16 | -0.36 | -0.48 | 0.17 | 0.00 |
| Enterprise Value Multiple | 5.82 | 7.69 | 11.08 | 7.28 | 10.86 |
| Enterprise Value | 8.18B | 5.89B | 10.61B | 10.51B | 12.38B |
| EV to EBITDA | 5.82 | 7.69 | 11.08 | 7.28 | 10.86 |
| EV to Sales | 1.57 | 1.19 | 2.23 | 2.22 | 3.14 |
| EV to Free Cash Flow | 291.59 | -20.98 | 40.69 | -105.54 | 22.13 |
| EV to Operating Cash Flow | 8.93 | 8.43 | 12.89 | 22.79 | 16.23 |
| Tangible Book Value Per Share | 1126.06 | 1159.37 | 801.78 | 723.52 | 440.86 |
| Shareholders’ Equity Per Share | 1131.39 | 1163.08 | 802.50 | 724.57 | 442.05 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.22 | 0.24 | 0.39 | 0.33 | 0.36 |
| Revenue Per Share | 1018.77 | 966.24 | 1145.28 | 1138.77 | 787.06 |
| Net Income Per Share | 155.52 | 49.11 | 92.20 | 199.23 | 117.18 |
| Tax Burden | 0.78 | 0.76 | 0.60 | 0.67 | 0.64 |
| Interest Burden | 0.97 | 0.90 | 0.97 | 0.97 | 0.96 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.31 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.90 | 2.78 | 1.30 | 0.37 | 0.83 |
Currency in JPY

